Renaissance Technologies’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
SCM
BGI
JT
OCA
PA
RCM
Renaissance Technologies's PALI Position: Q2 2026 in Review
Renaissance Technologies reduced its Palisade Bio (PALI) stake by 23% in Q2 2026, selling an estimated $649K and leaving 1,124,800 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1866.
Renaissance Technologies first reported a position in PALI in Q2 2019 and has held it in 16 quarters since. The position peaked at $5.6M in Q4 2025. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.
- Renaissance Technologies held 1,124,800 shares of Palisade Bio worth $2.35M as of Q2 2026.
- Renaissance Technologies sold 329,600 Palisade Bio shares in Q2 2026, an estimated $649K.
- Palisade Bio made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1866 holding.
- Renaissance Technologies first reported a position in Palisade Bio in Q2 2019 and has held it in 16 quarters since.
- Renaissance Technologies's Palisade Bio position peaked at $5.6M in Q4 2025.
- 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.